Published in Medical Letter on the CDC and FDA, May 24th, 2006
These new findings build on the previously demonstrated ability of Cyberkinetics' Andara OFS Device, used alone, to restore sensation and some function in a Phase Ia clinical trial of ten...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA